000 | 01382 a2200421 4500 | ||
---|---|---|---|
005 | 20250514051651.0 | ||
264 | 0 | _c20021210 | |
008 | 200212s 0 0 eng d | ||
022 | _a0820-3946 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown, Jacques P | |
245 | 0 | 0 |
_a2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. _h[electronic resource] |
260 |
_bCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _cNov 2002 |
||
300 |
_aS1-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aCanada |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDiet |
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 | _aEstrogens, Non-Steroidal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIsoflavones |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoporosis _xdiagnosis |
650 | 0 | 4 | _aPhytoestrogens |
650 | 0 | 4 | _aPlant Preparations |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aJosse, Robert G | |
773 | 0 |
_tCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _gvol. 167 _gno. 10 Suppl _gp. S1-34 |
|
999 |
_c12234867 _d12234867 |